- Perhaps the biggest narrative on CNBC in the past few months was that the markets wanted divided government. This didn't happen and the market is booming. Be wary of what you hear in the financial news.
- Daily Market Recap - Wednesday, January 6, 2021
- APXT Deep Dive Analysis
- Is SUMO IPO a hidden tech gem?
- Updated Price Targets for NIO
- Is this a bad time to start investing?
- Anyone else have a good day then wake up in the exact place they were the day before?
- Watchlist: 1/6 Winners and Losers - Weed, Oil, Tech, Dems
- LGVW Deep Dive Analysis
- Trading View (Pro+) - Difference in data between Daily and 30-min charts
- Guess the Company #3 (ticker trivia / due diligence)
- Hut 8 BC Miner TSX
- Bad time to add to Tesla position ?
- Is Exxon mobile a good buy if Democrats win senate in Georgia
- BFT Deep Dive Analysis
- ESPR - Esperion Therapeutics. Highly undervalued?
- Why is wall street on the rise?
- Stock Market News for Today | BABA | GM & Other Stock Market News [01-06]
- What do you guys use to evaluate stocks? Are these sites good?
- BTBT When there are more bashers, the more confident I feel
- Energy company recommandation and rate my holdings
- $INFY.. a hidden tech stock ready to explode tell me why it wouldn’t. 3.5 billion dollar contract secured
- Short term investments?
| Posted: 06 Jan 2021 08:36 AM PST Perhaps the biggest narrative on CNBC in the past few months has that the markets wanted divided government. This has been supported by nearly every anchor. This didn't happen and the market is booming. Be wary of what you hear in the financial news. I'm not saying I know for certain why the market is going up today. I'm saying that CNBC was so sure it would go down on a democratic sweep and that's clearly not happening. Be careful about agendas in financial news, especially CNBC. It's all just confirmation bias day after day. (Not saying it doesn't have entertainment value; just be careful.) [link] [comments]  |
| Daily Market Recap - Wednesday, January 6, 2021 Posted: 06 Jan 2021 01:38 PM PST PsychoMarket Recap - Wednesday, January 6, 2020 After climbing throughout the day, stocks pulled back in the last few hours of the session as turmoil in Washington D.C. escalated. The S&P 500 (SPY) finished 0.56% up, the Dow Jones (DIA) 1.43% up, and the Nasdaq (QQQ) finished 1.39% down. Today, as lawmakers debated President-Elect Biden's election victory, protesters in support of Donald Trump broke through the barricades and flooded the Capitol Building. In response, the building was placed under lockdown and Trump deployed the national guard and other law enforcement agencies to control the chaos. According to the Associated Press, one person was shot in a violent clash with the police. The unnamed person was rushed to the hospital, though their condition is not known. Mayor Muriel Bowser ordered a city-wide curfew from 6 p.m. until 6 a.m. In Georgia, Democratic Raphel Warnock defeated incumbent Kelly Koeffler to win one of the two Senate seats in the state. This gives Democrats 49 seats to the Republicans 50, with one seat still hanging in the balance. The race between incumbent Republican David Perdue and Democratic challenger Jon Ossoff remains too close to call at the time of writing and will decide which party has the majority position. Remember, in the case of a 50/50 tie, the Vice-President (Kamala Harris after January 20) casts the tie-breaking vote. As of Monday morning, the first doses of a COVID-19 vaccine had been given to more than 4.5 million people in the U.S., far below the Trump Administration promise of vaccinating 20 million Americans by years-end. Dr. Anthony Fauci said President-elect Joe Biden's goal of ramping up distribution to vaccinate 100 million people in his first 100 days was a "realistic goal," according to an interview with ABC on Sunday. Highlights
"If you set your goals ridiculously high and it's a failure, you will fail above everyone else's success." -James Cameron [link] [comments]  |
| Posted: 06 Jan 2021 06:12 AM PST APXT11/30/20 425 Filing: Transcript of APXT merging with AvePoint "AvePoint is the leading cloud software company for data governance and management in the Microsoft Cloud ecosystem. When we were looking for a company to merge with, we had five criteria. We wanted a company who is growing fast; profitable in a large market with great technology and experienced technical leadership and we found all five, check, check, check, check, check. So, we're very excited about merging with AvePoint." Key Points: AvePoint is still an emerging SaaS company with 19 years of experience. They've met high growth criteria and have the resources of a large company, working in tandem with Microsoft and have access to software components where businesses only focus on one or two components. "We now have to file the merger proxy with the SEC and the deal is expected to close in the first quarter." Excited for this merger as APXTU and APXTW now will be convertible as they expire 30 days after the complete business merger. It also gives us some time to do further research on AvePoint if necessary. AVPT new ticker symbol "Cloud software is growing very fast within the enterprise software world and there are 212 cloud software companies today that are public and if you use those criteria of scale, $150 million up in revenue in that range. Growth, 25% or faster growth and profitable, 10% or higher profit margin. Only five of those 212 companies meet that criteria and AvePoint will be the sixth. We're growing our ARR and our recurring revenue by 30%. We have a 14% profit margin and we have a very large market in the Microsoft ecosystem." Key Points: Some major statistics not only showing the rapid emergence of these companies in software and cloud computing, but also showing how AvePoint has been very successful in an increasingly diluted market. 12/07/20 8K Filing: Stock: APXT Warrants: APXTW Units: APXTU Units contain ½ a Warrant. One warrant redeemable for Class A stock at $11.50 share price. 11/24/20 425 Filing: "Yes. Over 50% of our revenue comes from regulated industry, so public sector as an individual vertical is the biggest industry for us. That's U.S. government, Western European government, Japanese, Singapore, Australia, and New Zealand government, then followed closely by financial services, healthcare, pharma, so very much regulated industries, manufacturing as well. Because again, our pedigree, where we started from is that we very much focus around Microsoft enterprise content management that was SharePoint on-prem and then we moved to cloud." Key Points: AvePoint is similar to Palantir with respects to having contracts and recurring revenue with governments. AvePoint provides their services more globally as well as having a variety of services to offer. "If I can add, to follow-up on that, we're growing our enterprise sales team by 50%, which is going to give us tremendous leverage and getting more new customers." Key Points: Marketing will increase, 80% of their revenue is recurring, AvePoint is now increasing their marketing efforts. Small businesses are also a great niche they pointed out during the call. Although slightly different needs, AvePoint has software for everyone. "In this program, we're top five globally, in the same group as DocuSign, Adobe, so asymmetrically, we're very, very important to the Microsoft sales team, but today, less than 10% of revenue come from referrals that way. We are looking to significantly scale our business, as we said, the addressable market is so vast. Just Teams active user seats alone is 150 million; Office 365, in aggregate, is 250 million. We have 7 million today and we want to grow very, very quickly. The best way to capture that market share, it's channel, it's scaling through indirect sales, so that's what we're doing." Key Points: Working with Microsoft, AvePoint has grown into their own shell, only having 10% of revenue coming from the Microsoft partnership. High growth and strong self-reliance show a growing company who can fend its own against competition. "We have point competitors in the enterprise space, because we are offering the end-to-end information management story with a singular SaaS multi-tenant platform. For example, we have, just in the back of the enterprise space, we can compete against Commvault, for example, if Commvault is backing up the entirety of the enterprise. They will use Commvault for backup, but then they will use us for governance, right, for other aspects of our information management capabilities ." Key Points: AvePoint provides all different software needs, competing with other companies not on the entire software package, but certain aspects such as data management or cloud allocation. They can work with competition and their niche is really that they have everything so they can profit from a variety of softwares. Found under 11/23/30 8K Filing https://www.sec.gov/Archives/edgar/data/0001777921/000121390020038639/ea130364ex99-2_apextech.htm An interesting presentation on AvePoint acquisition. I didn't look through the whole thing, lots of statistics, but I've gained from the discussion in 425 Filings that they've been successful and can continue to grow through the COVID-19 Pandemic and then as businesses still require cloud management and data storage. [link] [comments]  |
| Is SUMO IPO a hidden tech gem? Posted: 06 Jan 2021 01:26 PM PST 2.5 Billion market cap 155Million revenue IPO'd in September. Compared to its competitors, this stock seems like a good deal. Stock price target by analysts is 30$ Currently stock is $25.68 Haven't heard anyone talk about SUMO ipo on Reddit, feel like that's a good thing. [link] [comments]  |
| Posted: 06 Jan 2021 04:54 AM PST Daiwa securities 70$ (updated today) Credit suisse 65$ (updated today) CICC 60$ Goldman sachs 59$ Bank of america 59$ J.p morgan 50$ Deutsche Bank 50$ [link] [comments]  |
| Is this a bad time to start investing? Posted: 06 Jan 2021 04:22 PM PST I have always wanted to invest as soon as I turn 18 and I turn 18 next week but with everything that's going on I'm worried if it a bad idea to start now, I see a lot of people on these subs are taking their money out of their positions. I will start off with small amounts of money so it isn't a big deal if I lose by the way [link] [comments]  |
| Anyone else have a good day then wake up in the exact place they were the day before? Posted: 06 Jan 2021 04:18 AM PST I'm consistently ending my days with 0.5-3% returns. But every time I wake up and check it, it's right back down. Anyone else experiencing this luck? It is possible for it to open higher, so why hasn't that happened to me (literally not once)? I'm tempted to delete the apps and check back in a few months, but I don't wanna be surprised when I get taxed in February lol [link] [comments]  |
| Watchlist: 1/6 Winners and Losers - Weed, Oil, Tech, Dems Posted: 06 Jan 2021 03:34 AM PST Market Notes:The elections have yet to be called but the betting odds paint a clear picture. The Democrats swept the runoff elections pulling off a major upset victory. The liberal party will control the federal government for the next two years. Weed stocks are up, tech stocks are down. Many people have been calling for a market correction if this happened. I'm going to be very cautious while the market sorts out the results. Bitcoin appears to be the big winner, setting new all-time highs overnight. Oil surged above $50 per barrel yesterday for the first time since the pandemic crash. Energy stocks are likely in play this morning. Nasdaq futures have been down as much as 2%. The Dow and S&P 500 are mixed closer to flat. Watchlist:*ENSV has support at $2.35 *MYSZ watching for a setup above $1.70 *ZKIN has support at $3.20 *ESSC is on watch *SOL has support at $13 *GRTS has support at $5 CLSD has resistance at $4 RESN has support at $3, resistance at $4 PAVM has support at $2.50 CDMO has support at $12 MBIO has resistance at $4.36 SLCA watching for a setup above $9 LBRT has support at $11.50 GLOG has support at $4 ISR is on watch OII has support at $9 SM has support at $7 MTDR has support at $14 TIGR has support at $9.50 PTEN has support at $5.80 AMRS watching for a setup above $8 NEX has resistance at $4 NXE watching for a setup above $3 [link] [comments]  |
| Posted: 06 Jan 2021 09:50 AM PST LGVWButterfly Network merger- Handheld ultrasounds on a chip. Handheld Ultrasound- Heart exam, other health data. Convenience 📷 The handheld ultrasound has a plethora of medical uses. This adds a convenience factor and can reduce hospital costs. Personally not sure how much it will affect your hospital bill, but it should theoretically decrease costs. 📷 Minimal training time. It's all about convenience. Very accurate in multiple medical practices. "Mass market solution, not a niche market" 📷 Major focus on software and product. Symbiotic relationship between developing wearable health accessories and upgrading their software. Projected growth between the ultrasound and the wearables. 📷 Just a personal view of the company. Expected growth 10.6x. With LGVW shares trading at $10.00, it is a bargain to invest in Butterfly as they are expected to have almost double the revenue of these other growing industries. And 77% is only expected from ultrasounds, excluding wearables expected in 2023. So if their expected revenue is 77% growth and this isn't counting another source of revenue in 2023, then they are really expecting to take off. Backed by Bill and Melinda Gates Foundation in funding. See Attached SEC Filing for full Presentation (Excludes videos which can be found on investor page of Butterfly): https://www.sec.gov/Archives/edgar/data/0001804176/000110465920127916/tm2036551d1_425.htm LGVW- Class A Common Stock LGVW WS- Warrants LGVW U- Class A Common Stock and ⅓ Warrant Usual IPO of $10.00 with one warrant redeemable for $11.50 Excerpts from 11/27/20 S4 Filing: "Traditional cart-based equipment typically ranges from $45,000 to $60,000 per new device in the mid-range and is required to be operated by trained healthcare professionals. More recently, we have seen the introduction of Point-of-Care Ultrasound ("POCUS") devices with an average price point of $21,000, based on $5,000 to $7,000 per probe, generally requiring two to three probes to cover a comparable range of cleared indications to the single probe Butterfly iQ+. Butterfly iQ+'s price through our eCommerce website is $1,999 per device, making it a high-quality and affordable alternative to the costly traditional cart-based equipment and other handheld devices currently on the market." Analysis: A cheaper, more convenient method to full-body imaging. Creates access to thousands of doctors globally. "Our ultrasound system has been cleared by the FDA for the following uses: peripheral vessel (including carotid, deep vein thrombosis and arterial studies), procedural guidance, small organs (including thyroid, scrotum and breast), cardiac, abdominal, urology, fetal/obstetric, gynecological, musculoskeletal (conventional), musculoskeletal (superficial) and opththalmic." Analysis: FDA approval for multiple uses. Can be considered very cost efficient with the range of capabilities at a fraction of the cost of today's medical instruments. "We generated total revenue of $27.6 million and $1.5 million in the years ended December 31, 2019 and 2018, respectively, and $30.6 million and $16.8 million for the nine months ended September 30, 2020 and 2019. We also incurred net losses of $99.7 million for the years ended December 31, 2019 and $139.8 million in the nine months ended September 30, 2020." Analysis: Losing quite a lot more than total revenue. $75 million lost 2019 year and $100 million nine months ended September 30, 2020. COVID definitely affected revenue so may not be a prime indicator of the success of the company. "During the nine months ended September 30, 2020, our product revenue represented approximately 84.0% of our total revenue for the period, and our subscription revenue represented the remaining 16.0% of our total revenue for the period. As our devices continue to be adopted by more healthcare practitioners and practitioners in the Butterfly network continue to use our devices, we expect total subscription revenue to increase and that our subscription revenue will become an increasingly important contributor to our overall revenue" Analysis: At the moment, heavy reliance on tangible items, but will see a shift as more intangible subscriptions increase as it becomes similar to SaaS system. "In addition, if we do enter the direct-to-consumer market, we anticipate that our SDK would help with adoption and retention: as users create applications, our platform would become more personalized to them, which could encourage consistent use. Eventually, as these applications are deployed across the whole user base, we believe this would create a cycle, leading to more product enhancement and drawing in more users." Analysis: Will later rely on software and user influence in developing software to help others. Expecting a cycle of development by medical users with new and increasing needs, and allowing this new software to attract more users. 📷 The tangible market for ultrasounds. $2bn service market also available with room to grow as handheld ultrasounds increase simultaneously. 📷 Available market for Butterfly. Wearables are not yet available, expected 2023 but this shows future markets. "We offer a Pro subscription for $420 per year with one user license included, a Pro Team subscription for $1,200 per year with five user licenses included, and an enterprise subscription with tiered level pricing. We also sell accessories that supplement our device, including a carrying case, charger (complimentary with the purchase of the device), holster, and cable accessories." Analysis: Subscription pricing that is separate from the handheld ultrasound. Most likely will benefit with the subscription. Seems inexpensive for the capabilities, but I don't know the medical industry so can't really deem it a cheap or expensive subscription. [link] [comments]  |
| Trading View (Pro+) - Difference in data between Daily and 30-min charts Posted: 06 Jan 2021 07:27 PM PST On the chart of RH, the daily timeframe shows open of $480 on December 28, while the 30-min timeframe shows an open on $470 on the same day. That is a spread of a whopping $10 and I realized that today while trying to plan my exit. Is this common or am I seeing something wrong? I have attached photos for reference. Thanks! [link] [comments]  |
| Guess the Company #3 (ticker trivia / due diligence) Posted: 05 Jan 2021 09:38 PM PST Previously on Guess the Company Hi fellow kids, I'm back again today with yet another DD where I reveal the ticker at the end rather than the beginning. Let's see how many clues it takes for you to correctly guess today's company: -This company's Q2 2020 revenues dropped 98% compared to a year ago, and its quarterly EPS plunged from $1.24 in Q2 2019 to a loss of ($1.07) in Q2 2020. -Despite these revenue numbers, shareholders were barely fazed and the stock continued to trade sideways between $40-$50 from June to November 2020 -If you bought $10000 of this stock at its all time low in March 2009, you would be receiving about twice that much in annual dividends up until it was suspended in Q2 2020 due to the pandemic -As part of the terms of a $1.5 billion credit facility, this company is not permitted to pay dividend until Q4 2021 unless it can maintain a $1 billion+ liquidity after paying the dividend. -During the height of the financial crisis in 09, this company was reportedly losing $1000 per *second* -When this company was about to go bankrupt, its owner dug into his own pockets and loaned the company $1 billion -Before his company's stocks took a nosedive in 2008, the owner of this company was briefly the 3rd richest person in the USA behind only Bill Gates and Warren Buffet -Although this company is based in Paradise, NV, the majority of its revenues comes from China. More specifically, Macau, China. -In 2010 this company built a $6.88 billion resort in Singapore, billed the world's "most expensive standalone casino property" -With annual revenues of $14 billion, this company is the largest casino operator in the world by market capitalization Have you made your guess yet? If your guess was LVS , you are correct! Outlook for LVS: There are speculations that LVS might sell its Las Vegas Strip properties to a REIT and then lease them back, a move that would raise about $6 billion and allow it to further focus its efforts in Asia where most of its revenues come from. Although my outlook for LVS is bullish, I expect this stock to trade mostly sideways until later this year or early 2022 when it resumes paying dividends to shareholders. OPTAP: $75 [link] [comments]  |
| Posted: 06 Jan 2021 07:18 PM PST Seeing the run up of Riot, Mara etc. and looking for similar opportunities. hutmf trades on TSE. Market cap 292M Cdn. Own 3500 bc's. The value of those held coins is approx 56% of their current market cap. Mined approx 2500 new coins last quarter. Have set up with a financial institution and will get paid 4% interest on their held balances. Equates to $1.6M/Qtr. Stock at approx $3.90 Cdn, or $3.10 US. Feel like I must be missing something as to me this seems undervalued. Welcome any feedback re what I might be missing or other. Newbie so be gentle. [link] [comments]  |
| Bad time to add to Tesla position ? Posted: 06 Jan 2021 09:22 AM PST I have 21 shares in Tesla currently bought in March- may I let it ride from there and made a pretty decent profit. My average is 639 per share so should I dump more in now or wait ? Will it make a difference? [link] [comments]  |
| Is Exxon mobile a good buy if Democrats win senate in Georgia Posted: 06 Jan 2021 12:11 PM PST Because Exxon is researching in carbon emission capturing and reduction and Democrats are looking to into carbon emission capturing technology will it be a good investment? [link] [comments]  |
| Posted: 06 Jan 2021 09:46 AM PST BFT425 Filing (One of many) https://www.sec.gov/Archives/edgar/data/0001818355/000119312520311318/d91054d425.htm "As part of the financing, I am pleased to announce that we have received commitments for a private investment of $2.0 billion anchored by title and life insurance subsidiaries of Fidelity National Financial, Third Point Asset Management and Maplelane Asset Management, which will be funded upon the conclusion of the combination which we expect to close in the first half of 2021." Analysis: Fidelity, Third Point, and Maplelan all support this business acquisition and will complete their investment after the completion of the merger. Shows strong faith in both companies and the possible growth. "Paysafe is a highly attractive and scarce investment opportunity within the payments and fintech space, where I believe we can add significant value to Philip and his team. Paysafe has an attractive combination of payment assets including a leading digital wallet platform in Skrill, one of the fastest growing eCash businesses, and a merchant business focused on high growth vertical markets. We will help Phillip and his team identify additional cost savings, focus on the most attractive organic revenue growth opportunities and identify and execute strategic acquisitions. With a proven strategy, an experienced management team and our newly formed partnership, we believe Paysafe has significant long-term growth potential." Analysis: Paysafe has multiple assets that allow them to invest into multiple areas of ecommerce. Digital wallets, different cash payments. They're looking to merge with BFT to cut costs and increase revenue at a higher rate of growth than Paysafe is expecting to perform on their own. "These improvements will come in various tracks. First, it's going to be in total project cost savings from platform integration. We're also going to have a 30% reduction in Premise's office footprint. We'll have back office consolidation in risk compliance and operations. And, the risk platform is going to save another $15 million from fraud reduction, good and bad rate improvement, credit loss improvement, and digital wallet funding enhancements. We also believe there is an opportunity to improve Paysafe's banking relationships generating additional cost saves, adding to EBITDA growth." Analysis: Looking to increase EBITDA growth with BFT. Their strategy is to reduce spending costs and increase risk management with their assets as well as the clients. Paysafe is also looking to increase relationships with other online transactors. "Lastly, our primary goal is to win in US iGaming. Ten percent of the US iGaming market share is forecasted to grow to $24 billion of market volume in 2025. The upside case is about $47 billion of market volume. Remember that Paysafe has a global base of 15 million customers across all of its verticals. We have a proven strategy of winning as new global markets open. And most importantly, we have unrivalled regulatory risk and technical expertise." Analysis: Paysafe controls 100% iGaming in Canada and has 75% of iGaming U.S. market. iGaming is 30% of their revenue and they are looking to control the entire market as there is continual growth with consistent users and younger generations. "In terms of who we service, we service millions of Gen Z and Millennial gamers. They're playing Fortnite and PlayStation or downloading songs on Spotify. We service the casual gamer that doesn't bet very often, maybe for the final four, or Super Bowl, or their favorite cricket team, but we also service millions of security conscious and under bank customers that don't want to expose their card online for general commerce." Analysis: Paysafe is attracting younger customers and has a strong control of the gambling area. Could have correlation with DraftKings. "Two totally separate platforms, totally separate sets of code. We've put them onto a single platform that would drive a lot more efficiency and speed to market." Analysis: a lot more efficiency and integration, trying to increase revenue by cutting down services" Paysafe example of increasing efficiency and cutting costs. "Paysafe has integrated 15 companies throughout its history, and the current executive team has done well over 300 deals combined, either negotiated and/or integrated, including many multi-billion dollar deals. There's a lot to combine here where we think we can drive some exciting consolidation as well." Analysis: Paysafe has experience acquiring companies, so we should keep a lookout for more BFT mergers. "Let me break that down as I walk down the funnel on the right-hand side of the page. Of the 4,300 listed companies, about 1,500 companies have revenues over $1 billion; we have $1.4 billion. Of the 1,500 companies, roughly 300 expect revenue growth over 10%; we are expecting 11%. Only 75 have margins greater than 30%, and only 40 of them are also supported by a capital light business model." Analysis: Paysafe has jumped all these hurdles, just statistical reasons why BFT believes Paysafe is a great growth company. "The first comp for us is always PayPal. While PayPal is a much larger and more scaled business, we do look at the playbook and their history of the last 10 years and the consolidation of platforms, successful expansion beyond their core roots, and then M&A to drive a massive value story. We absolutely see Paysafe as positioned for a very, very similar story, and with the same capabilities." Analysis: PayPal can be considered comparable to Paysafe with assets and possibilities of growth. 425 Filing: https://www.sec.gov/Archives/edgar/data/0001833835/000119312520311887/d166158d425.htm We expect the transaction to close in the second quarter of 2021 at which point Paysafe will be publicly traded on the NYSE." Under PSFE Stock: BFT Warrant: BFTW Units contain ⅓ of a warrant. One warrant allows convertible to Class A stock at $11.50 share price. 425 Filing: https://www.sec.gov/Archives/edgar/data/0001833835/000119312520311998/d54063d425.htm Presentation from initial 425 filing that goes along with the ViaVid Communications report. [link] [comments]  |
| ESPR - Esperion Therapeutics. Highly undervalued? Posted: 06 Jan 2021 05:11 PM PST I received an interesting stock recommendation today from a friend with considerable professional experience in financial services. He recommended Esperion Therapeutics (ESPR). It's a pharmaceutical company whose major product is being approved and rolled out worldwide - a drug that is used to control cholesterol, which is a major health concern for many. Their new drug, Nexletol, is better than Lipitor because many people are allergic to statins, of which Lipitor is. They just gained FDA and EU commission approval and have a major potential revenue incoming, which will only increase as COVID subsides. ESPR was driven down hard by COVID, and just now trading above its 52 week low. But here's the interesting part - He says institutions hold 122% of the shares and there is 42% short interest (as of Dec. 15th), a large majority of the institutional shares are likely in index funds that are not traded. If there is a squeeze, he says there is maybe 30% of the float in discretionary hands for the 42% shorts to buy back - so they might find it difficult to find shares to cover - they could get burned pretty badly in a squeeze. Institutions have likely accumulated even more since 12/15 and there are even less shares to cover a short. A considerable amount of that short is probably in option desks, and if you check out the options charts and you will see a grossly disproportionate amount of calls. Current trading price (as of last close) is $28.92 (a little over 1/3 the 52 week high) and the the analysts mentioned in my various trading/research accounts have price targets from $35 to $150, with an average of $63-74. Different ranking services have this as a Buy or Strong Buy. Looking at the charts, the Daily Price Rate of Change is accelerating. A big piece of news could double this in a week given it's modest market cap. What is he/am I missing? [link] [comments]  |
| Why is wall street on the rise? Posted: 06 Jan 2021 05:08 PM PST The Senate will probably go to democrats now which means Joe Biden's tax reforms for capital gains and income tax are likely going to materialize then why is the market increasing? Shouldn't the market go down because it's bad for investors? Plus the environmental reforms he is going to bring are going to be a problem for big corporation. I am so amused that the market is still going up. [link] [comments]  |
| Stock Market News for Today | BABA | GM & Other Stock Market News [01-06] Posted: 06 Jan 2021 05:29 AM PST What is the impact of the Georgia Election on the Stock market? Is Alibaba going to recover or is it going down? GM outperforms in 2020, let's talk about this and other stock market news Hello everyone and Good Morning! So, let's start with the recap of yesterday as we saw the stock market recovering a good part of the losses from the first trading day of 2021, as the Nasdaq Composite gained almost 1%, the broad stock market SP500 rose by .71% and the Dow Jones finished 167 points higher. We also saw the VIX dropping by more than 6% after the huge spike on Monday as more than 70% of the companies were advancing yesterday on average volume with 109 new highs. We saw 8 of the 11 SECTORS finish the day in the green, lead by Energy up over 4% and Materials up over 2%, while Consumer staples finished flat and Utilities & Real Estate just finished in the red. Most small & mid-cap value & core companies were outperforming yesterday, as large-caps did finish mostly flat. Here is the HEAT MAP from yesterday which revels plenty of gains in most of the areas of the stock market, with Big Tech companies advancing moderately, while most of the Oil& Gas industry finished up significantly higher alongside companies from China. The economic data that we received yesterday was mostly positive, starting with bankruptcy fillings falling to the lowest monthly number since early 2006, continuing the trend of this year, as this number, is the lowest we have seen since 1986, as companies have been hugely supported by fiscal and monetary policies with record-breaking capital injections. We also saw the December ISM Manufacturing INDEX coming at 60.6, higher than the 56.6 expected and the 57.5 in the previous month. This was led by a growth in new orders, productions, prices index & supplier deliveries, while the employment index changed direction and was in expansion territory again this month, standing at 51.5. This was the highest PMI we have seen in 2020, with December being the 7th straight month of expansion and the biggest one of this year, with this PMI corresponding to a 5.2% increase in GDP on an annualized basis, as we also saw a 5.5% increase on a yearly basis in the latest Redbook chain store SALES. TODAY we continue to get auto sales numbers, MBA mortgage applications, ADP jobs numbers, factory orders and a final read on the PMI composite, as we also await the Georgia Runoff ELECTION final results, as right now one of the seats has been called by multiple media channels for the Democrats while the other one is still too tight to call. If the Dems to sweep, this could cause an increased volatility in the markets, especially in the tech sectors as investors would probably overreact and just start selling off. This could be a good buying opportunity in my opinion, as I believe it's very unlikely that even if Democrats do have the power to make big changes, which is very unlikely on big & important subjects as they themselves are divided on many subjects, they wouldn't do that when things are still very bad in the economy, and the future still looks uncertain. Things should get better before any "big tax changes" or any other "big regulation changes". So, if the Dems win the other seat, expect volatility, that could lead to a healthy correction after a huge run or a consolidation period before the markets recovers. So, I just wouldn't bet against the bull market that we are in right now. In some other stock market news, we saw a report that Alibaba is planning to raise $5B through bonds again, following the 2014 and 2017 capital raising operation, with the company also getting downgraded at CFRA to a sell rating while also cutting their PT from $280 to $210. I know the political factors are really pushing this stock in the wrong direction, but after all of this will pass, Alibaba is still a great company, even without Ant Group and despite the latest moves by trump to continue banning Chinese APPS, with the latest big ones being Alipay & WeChat Pay. In my opinion this is a severe overreaction as long-term investing goes. Yeah, maybe in the short-term the company can go either way depending on what restrictions they get, but I really don't think Alibaba will go bust in the long-run. Yesterday we also receive auto sales number from a couple of manufacturers, with GM stealing the show, with Q4 sales up almost 5% year/year, as the company estimated they gained market share in both retail and fleet deliveries in 2020, while NISSAN's sales continued to drop, as they sold 19% less vehicles in Q4 over the last quarter, as the total sales in 2020 dropped by more than 33%, as the automaker has fallen out of flavor with outdated models and no innovative developments. Meanwhile VW did slightly worse overall in 2020, but saw a 11% increase in sales in Q4, as this was led by a 22% increase in the total SUVs sold. The SUV trend continues to keep on getting more & more meaningful and most automakers must try and compete in this highly demanded market if they do want to survive. If you do want to invest in this industry, I suggest you take a look at the product development & future outlook for the company before. I think both GM & Ford are going in the right direction, but you should do your own research. So, let's hope for a good day in the market as the world stock markets and the US FUTURES seem to be pointing to a mixed open, with the Dow leading the way, while the tech heavy Nasdaq is down almost 1.3% on panic selling & portfolio rebalancing happening due to the possible Democratic sweep in Georgia. Thank you everyone for reading! Hope you enjoyed the content! Be sure to leave a comment down below with your opinion on the stock market! Have a great day and see you next time! [link] [comments]  |
| What do you guys use to evaluate stocks? Are these sites good? Posted: 06 Jan 2021 09:44 AM PST Hi. New to the market and have been learning for the past 6 months. Im aware of TradingView and Marketwatch. Are those good resources if I wanted to use the following factors to evaluate a stock? -How do they make money? How does their product do well? -Longevity of the business. Can you own it for 10 years? More assets than liability -Expansion - can the business expand without selling off assets? -Have they consistently increased profits? Or do you guys use/recommend other resources where this information can be easily obtained? [link] [comments]  |
| BTBT When there are more bashers, the more confident I feel Posted: 06 Jan 2021 10:59 AM PST BTBT When there are more bashers, the more confident I feel. These people that try trick new investors into switching to other stocks because they either sold too early or didn't get into the stock in time. If you have acc done your research, you know this stock is a winner. This company has been in the works for a long time and it is finally getting the recognition is deserves. Big news is coming out this entire month. With more news and studies supporting their innovating movements with sapphire, the more this stock will grow. If you are trying to make a quick buck then leave bc this stock isn't for you. You can expect a company to just keep increasing without health pushbacks and dips. Patience always wins but do as you wish. If you have already invested in this stock, remember why you invested initially. Don't let these people manipulate your actions. You do what you feel is correct and don't be pressured by others. Know what you own .. 3 B market cap is bare minimum ie 15 20 short term PT.
2.Gene discovery leads to better diagnoses and cure for all diseases. 3.bio/ Nano genomics exists since 2003. IPOed in 2018 at 8.Its stock price was punished as they were trying to sell Saphyr platform. They have shifted to service model.140 % increase in revenues.. 4.Harvard,Mayo clinic, Augusta University, Max Plank. etc use their genomics platform. 5.FDA would surely approve it as this is the ONLY platform. 6.100 + Patents.. 7.vanguard/,UBS Securities and JP morgan already invested. ARKG may follow suit. This is an important company that will forever change humankind. If they are able to detect diseases by their genome mapping machine Saphyr, so you don't see your loved ones slowly deteriorate by cancer etc, I'm all in. I want them to succeed! This is like discovering penicillin! I rather buy this then palatir! We are at the dawn of a new company. I wish it drops more as I'm going to buy even more. This company will be big in the future and you can be part of it by owning part of it. The biggest experts on cytogenomics are gathering up from January 11th to January 15th to discuss how powerful and innovative Saphyr is. Analysts have a BUY rating. Vanguard owns 5m shares. Optical mapping is the key to discover rare structural variations. Need I say more? $BNGO It's completely oversold with absolutely NO bad news... The biggest catalyst is next week when they reveal the great potential of Saphyr with researchers from around the world. It is a 5-day event, not 1 day.. it will take 5 days to discuss the potential applications of Saphyr in genome world. PENDING FDA APPROVAL PLUS ITS already equivalently FDA approved in 2 other countries so it will get FDA approval here in the USA. [link] [comments]  |
| Energy company recommandation and rate my holdings Posted: 06 Jan 2021 10:48 AM PST Hi, Newbie investor here. I'm trying to enlarge my portfolio into renewable, green energy or battery companies. Can anyone tell me good companies to look into? My holdings APTV 112€ 1 TSM 561€ 6 TGT 305€ 2 iShares S&P 500 397€ 13 I'm feeling that some people would say that I need to diversify but I couldn't find other good companies for the moment so my money is invested in these companies. I'm an apprentie so I don't really get paid much which explains the little sum of my investment :) I'm also thinking of investing some into crytocurrency but my inner voice keeps saying it's a bad choice bruh. What do you think about it? [link] [comments]  |
| Posted: 06 Jan 2021 10:08 AM PST Ticker: $INFY Earnings coming up 1/13/2021 Every year the company is making profit. Made 13 billion last year. All green ! A- credit rating, 3.5 billion dollar contract, 240k employees. This is a hidden gem and will skyrocket. This is a great buy IMO nothing but green idk how people are not looking into this stock. They are all over the world [link] [comments]  |
| Posted: 06 Jan 2021 11:55 AM PST I'm really new to investments and the stock market. The only thing I know about investments are retirement funds like 401(k)s and IRAs. But how do I invest for shorter terms? I've seen some people warn against short term gains due to taxes but is that the best way to get the most money? I'm just trying to save up for a house and pay off my car which I don't see myself doing just by putting money in a high yield-savings account. I'd appreciate any advice because I'm honestly super clueless. [link] [comments]  |
| You are subscribed to email updates from r/StockMarket - Reddit's front page of the stock market, financial news. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment